<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Dec 17, 2025</title>
<meta name="color-scheme" content="light" />
<style>
  :root { --maxw: 800px; color-scheme: light; }
  html { -webkit-text-size-adjust: 100%; }
  body {
    margin: 0;
    padding: 0;
    background-color: #ffffff;
    color: #111111;
    font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji;
    line-height: 1.6;
    font-size: 18px;
  }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

<span title="There are now">Ahora existen</span> <span title="two main options">dos opciones principales</span> <span title="for the prevention of RSV">para la prevención del VSR</span> <span title="in infants">en lactantes</span>: <span title="maternal vaccination">la vacunación materna</span> con RSVpreF <span title="during pregnancy">durante el embarazo</span> (Abrysvo) y <span title="the monoclonal antibody">el anticuerpo monoclonal</span> nirsevimab <span title="for the infant">para el lactante</span>. El ACIP <span title="recommends using">recomienda usar</span> <span title="these options">estas opciones</span> <span title="in a coordinated way">de manera coordinada</span>, y <span title="not to administer both">no administrar ambas</span> <span title="to most infants">a la mayoría de los lactantes</span>.

<span title="Maternal Abrysvo">Abrysvo materno</span> <span title="is a single dose">es una sola dosis</span> <span title="between 32 and 36 weeks of gestation">entre las 32 y 36 semanas de gestación</span> <span title="during RSV season">durante la temporada de VSR</span>. <span title="It helps protect">Ayuda a proteger</span> <span title="infants in their first RSV season">a los lactantes en su primera temporada de VSR</span>, <span title="which generally corresponds to">que generalmente corresponde a</span> <span title="the first 6 months of life">los primeros 6 meses de vida</span>.

<span title="For most infants">Para la mayoría de los lactantes</span>, <span title="Abrysvo should be used">se debe usar Abrysvo materno</span> <span title="at the end of pregnancy">al final del embarazo</span> o nirsevimab <span title="for the infant">para el lactante</span>, <span title="but not both">pero no ambos</span>.

<span title="If the pregnant person">Si la persona embarazada</span> <span title="receives Abrysvo">recibe Abrysvo</span> <span title="at least 14 days before delivery">al menos 14 días antes del parto</span>, <span title="most full-term infants">la mayoría de los lactantes a término</span> <span title="do not need nirsevimab">no necesitan nirsevimab</span>, <span title="unless they have">a menos que tengan</span> <span title="a very high risk">un riesgo muy alto</span>, <span title="such as">como</span> <span title="significant congenital heart disease">cardiopatía congénita significativa</span> o <span title="chronic lung disease">enfermedad pulmonar crónica</span>.

<span title="Infants born">Los lactantes nacidos</span> <span title="less than 14 days after maternal vaccination">menos de 14 días después de la vacunación materna</span>, <span title="born very prematurely">nacidos muy prematuros</span> o <span title="with poor transfer of maternal antibodies">con transferencia deficiente de anticuerpos maternos</span> <span title="can still receive nirsevimab">aún pueden recibir nirsevimab</span>.

<span title="If maternal vaccination was not given">Si no se administró la vacunación materna</span>, <span title="all infants under 8 months">todos los lactantes menores de 8 meses</span> <span title="in their first RSV season">en su primera temporada de VSR</span> <span title="should receive nirsevimab">deben recibir nirsevimab</span>, <span title="unless it is clearly contraindicated">a menos que esté claramente contraindicado</span>.

<span title="Abrysvo is not used">Abrysvo no se utiliza</span> <span title="in pregnancy">en el embarazo</span> <span title="if there was a severe allergic reaction">si hubo una reacción alérgica grave</span> <span title="to any component">a algún componente</span>. <span title="The safety data so far">Los datos de seguridad hasta ahora</span> <span title="are acceptable">son aceptables</span>.

<span title="The timing of administration">El momento de la administración</span> <span title="depends on">depende de</span> <span title="the local epidemiology of RSV">la epidemiología local del VSR</span>. <span title="In most regions of the US">En la mayoría de las regiones de EE. UU.</span>, <span title="it is recommended to give Abrysvo">se recomienda aplicar Abrysvo</span> <span title="at the end of summer">a fines del verano</span> o <span title="at the beginning of winter">al inicio del invierno</span>. <span title="Outside this period">Fuera de este periodo</span>, <span title="nirsevimab is used">se utiliza nirsevimab</span> <span title="for newborns">para los recién nacidos</span>.

<span title="In practice">En la práctica</span>, <span title="advise pregnant patients">aconseje a las pacientes embarazadas</span> <span title="to choose between">elegir entre</span> <span title="maternal Abrysvo between 32 and 36 weeks">Abrysvo materno entre las 32 y 36 semanas</span> o <span title="nirsevimab for the infant">nirsevimab para el lactante</span>. <span title="Plan according to">Planifique según</span> <span title="the probable due date">la fecha probable de parto</span> y <span title="the local RSV season">la temporada local de VSR</span>. <span title="This avoids extra doses">Esto evita dosis adicionales</span> y <span title="maintains protection">mantiene la protección</span>.

---
DIALOGUE

Narrator: <span title="Today we will talk about">Hoy hablaremos sobre</span> <span title="how to protect newborns">cómo proteger a los recién nacidos</span> <span title="from RSV">del VSR</span>.
Physician: <span title="RSV can make babies very sick">El VSR puede enfermar gravemente a los bebés</span>. <span title="We want to keep your baby safe">Queremos mantener a su bebé seguro</span>.
Patient: <span title="What can I do">¿Qué puedo hacer</span> <span title="to protect my baby">para proteger a mi bebé</span>?
Physician: <span title="There are two ways">Hay dos maneras</span>. <span title="One is a vaccine for you">Una es una vacuna para usted</span> <span title="in the last trimester of pregnancy">en el último trimestre del embarazo</span>. <span title="It is called Abrysvo">Se llama Abrysvo</span>.
Patient: <span title="When should I get this vaccine">¿Cuándo debo ponerme esta vacuna</span>?
Physician: <span title="The best time is">El mejor momento es</span> <span title="between 32 and 36 weeks of pregnancy">entre las 32 y 36 semanas de embarazo</span>, <span title="if it is during RSV season">si es durante la temporada de VSR</span>.
Patient: <span title="What happens if">¿Qué pasa si</span> <span title="I have my baby">tengo a mi bebé</span> <span title="shortly after the vaccine">poco después de la vacuna</span>?
Physician: <span title="If the baby is born">Si el bebé nace</span> <span title="less than 14 days after your vaccine">menos de 14 días después de su vacuna</span>, <span title="your baby might need">su bebé podría necesitar</span> <span title="another medicine">otro medicamento</span>.
Patient: <span title="What is that other medicine">¿Cuál es ese otro medicamento</span>?
Physician: <span title="It is called nirsevimab">Se llama nirsevimab</span>. <span title="It is an antibody injection">Es una inyección de anticuerpos</span> <span title="for newborns">para recién nacidos</span>.
Patient: <span title="Do babies need">¿Los bebés necesitan</span> <span title="both the vaccine and the antibody">tanto la vacuna como el anticuerpo</span>?
Physician: <span title="Most babies only need one">La mayoría de los bebés solo necesita uno</span>. <span title="Choose the one">Elija el que</span> <span title="is best for you and your baby">sea mejor para usted y su bebé</span>. <span title="We can talk about">Podemos conversar sobre</span> <span title="the best plan">el mejor plan</span>.
Patient: <span title="Is the vaccine safe">¿La vacuna es segura</span> <span title="for me and my baby">para mí y mi bebé</span>?
Physician: <span title="The safety data are favorable so far">Los datos de seguridad son favorables hasta ahora</span>. <span title="If you had a severe allergy">Si tuvo una alergia grave</span> <span title="to this vaccine before">a esta vacuna antes</span>, <span title="you should not receive it">no debe recibirla</span>.
Narrator: <span title="Work with your doctor">Trabaje con su médico</span> <span title="to choose the best way">para elegir la mejor manera</span> <span title="to protect your baby from RSV">de proteger a su bebé del VSR</span>.
    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

RSV prevention for infants now has two main options: maternal RSVpreF vaccination in pregnancy (Abrysvo) and infant nirsevimab monoclonal antibody. ACIP says to use these in a coordinated way, not to give both to most infants.

Maternal Abrysvo is one dose at 32–36 weeks’ gestation in RSV season. It helps protect infants in their first RSV season, usually the first 6 months of life.

For most infants, use either maternal Abrysvo in late pregnancy or infant nirsevimab, but not both.

If a pregnant person gets Abrysvo at least 14 days before delivery, most term infants do not need nirsevimab, unless they have very high risk, like significant congenital heart or chronic lung disease.

Infants born less than 14 days after maternal vaccination, born very preterm, or with poor maternal antibody transfer may still get nirsevimab.

If maternal vaccination was not given, all infants under 8 months in their first RSV season should get nirsevimab, unless clearly ineligible.

Abrysvo is not used in pregnancy if there was a severe allergic reaction to any component. Safety data so far look acceptable.

Timing depends on local RSV epidemiology. In most U.S. areas, give Abrysvo in late summer to early winter. Outside this time, use nirsevimab for newborns.

In practice, counsel pregnant patients to choose either maternal Abrysvo at 32–36 weeks or infant nirsevimab. Plan based on due date and local RSV season. This avoids extra doses and keeps protection.

---
DIALOGUE

Narrator: Today, we talk about how to protect newborns from RSV.
Physician: RSV can make babies very sick. We want to keep your baby safe.
Patient: What can I do to protect my baby?
Physician: There are two ways. One is a vaccine for you in late pregnancy. It is called Abrysvo.
Patient: When should I get this vaccine?
Physician: The best time is between 32 and 36 weeks of pregnancy, if it is during RSV season.
Patient: What if I have my baby soon after the vaccine?
Physician: If the baby is born less than 14 days after your shot, your baby may need another medicine.
Patient: What is the other medicine?
Physician: It is called nirsevimab. It is an antibody shot for newborns.
Patient: Do babies need both the vaccine and the antibody?
Physician: Most babies need only one. Pick the one that is right for you and your baby. We can talk about the best plan.
Patient: Is the vaccine safe for me and my baby?
Physician: Safety data looks good so far. If you had a bad allergy to this vaccine before, you should not get it.
Narrator: Work with your doctor to choose the best way to protect your baby from RSV.
    </details>
  </main>

  <footer class="subtle">
    <div>© Dec 17, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>